Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zosano
Pharma
Zosano suspends migraine patch program after FDA knockback
Zosano has suspended its M207 transdermal migraine patch program and made more layoffs to preserve its dwindling cash reserves.
Nick Paul Taylor
May 3, 2022 1:34pm
Zosano plots 2021 resubmission for once-rejected migraine patch
Apr 27, 2021 7:50am
Spectrum's Rolontis delayed amid COVID-19 travel restrictions
Oct 27, 2020 8:49am
Zosano presses on after FDA rejects Qtrypta migraine patch
Oct 23, 2020 8:35am
